Product Images Voraxaze
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 2 images provide visual information about the product associated with Voraxaze NDC 50633-210 by Btg International Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Package Label - Principal Display Panel - VORAXAZE Vial - voraxaze figure 1
Voraxaze® (Glucarpidase) is an injectable medication with NDC code 50633-210-11. A readable price is not available.*
Package Label - Principal Display Panel - VORAXAZE Carton - voraxaze figure 2
This text contains information related to Voraxaze® medication, which is a Glucarpidase medication for injection, which is available in single-use vials. The package's sole vial contains 1000 units of Glucarpidase, lactose monohydrate, Tris-HCI, and zinc acetate dihydrate with dosage instructions and other information. Voraxaze® is a registered trademark of Proterics Medicines Development L, and the medication is manufactured by BTG International Inc. located in Brentwood, TN, USA. The package also contains information regarding storage conditions and precautions related to the medication.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.